XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.2
Note 15 - (Loss) Earnings Per Share
6 Months Ended
Jun. 30, 2023
Notes to Financial Statements  
Earnings Per Share [Text Block]

NOTE 15 (LOSS) EARNINGS PER SHARE

 

The following table sets forth the reconciliation of numerators and denominators for the basic and diluted (loss) earnings per share computation for the three and six months ended June 30, 2023 and June 30, 2022:

 

(in thousands, except per share data)

 

Three months ended June 30,

  

Six months ended June 30,

 
  

2023

  

2022

  

2023

  

2022

 

Numerator:

                

(Loss) income from continuing operations

 $(1,777) $(3,151) $25,955  $(7,150)

Plus (less): net loss (income) from continuing operations attributable to noncontrolling interests

  227   (180)  230   (107)

Less: dividends on preferred stock

  (5)  (79)  (74)  (157)

Numerator used in calculating basic (loss) earnings per share from continuing operations attributable to common shareholders

 $(1,555) $(3,410) $26,111  $(7,414)

Adjustment to add-back dividends on preferred stock

        74    

Adjustment for proportionate interest in Ravix and SNS's earnings attributable to common stock

        (91)   

Numerator used in calculating diluted (loss) earnings per share from continuing operations attributable to common shareholders

 $(1,555) $(3,410) $26,094  $(7,414)

Income from discontinued operations

  110   786   217   2,281 

Less: net income from discontinued operations attributable to noncontrolling interests

     (123)     (345)

Numerator used in calculating diluted (loss) earnings per share - net (loss) income attributable to common shareholders

 $(1,445) $(2,747) $26,311  $(5,478)
                 

Denominator:

                

Weighted average basic shares

                

Weighted average common shares outstanding

  25,295   22,883   24,681   22,883 

Weighted average diluted shares

                

Weighted average common shares outstanding

  25,295   22,883   24,681   22,883 

Effect of potentially dilutive securities (a)

                

Unvested restricted stock awards

        812    

Warrants

        1,357    

Convertible preferred stock

            

Total weighted average diluted shares

  25,295   22,883   26,850   22,883 

Basic (loss) earnings attributable to common shareholders:

                

Continuing operations

 $(0.06) $(0.15) $1.06  $(0.32)

Discontinued operations

 $  $0.03  $0.01  $0.08 

Basic (loss) earnings per share - net (loss) income attributable to common shareholders:

 $(0.06) $(0.12) $1.07  $(0.24)

Diluted (loss) earnings attributable to common shareholders:

                

Continuing operations

 $(0.06) $(0.15) $0.97  $(0.32)

Discontinued operations

 $  $0.03  $0.01  $0.08 

Diluted (loss) earnings per share - net (loss) income attributable to common shareholders

 $(0.06) $(0.12) $0.98  $(0.24)

 

 

(a)

Potentially dilutive securities consist of unvested restricted stock awards and warrants, calculated using the treasury stock method, and convertible preferred stock, using the if-converted method. Because the Company is reporting a loss from continuing operations attributable to common shareholders for the three months ended  June 30, 2023 and the three and six months ended  June 30, 2022, all potentially dilutive securities outstanding were excluded from the calculation of diluted loss from continuing operations per share since their inclusion would have been anti-dilutive.

 

Basic (loss) earnings per share excludes dilution and is computed by dividing (loss) income attributable to common shareholders by the weighted-average number of common shares outstanding for the period.  Diluted (loss) earnings per share is calculated using weighted-average diluted shares. Weighted-average diluted shares is calculated by adding the effect of potentially dilutive securities to weighted-average common shares outstanding.  Potentially dilutive securities are excluded from the diluted (loss) earnings per share computation in loss periods and when the applicable exercise price is greater than the market price on the period end date as their effect would be anti-dilutive.

 

The following weighted-average potentially dilutive securities are not included in the dilut ed (loss) earnings  per share calculations above because they would have had an antidilutive effect on the (loss)  earnings   per share:
 
  

Three months ended June 30,

  

Six months ended June 30,

 
  

2023

  

2022

  

2023

  

2022

 

Unvested restricted stock awards

  1,146,947   1,252,754   335,540   1,252,754 

Warrants

  3,152,795   4,573,765   1,795,743   4,573,765 

Convertible preferred stock

     1,060,831      1,060,831 

Total

  4,299,742   6,887,350   2,131,283   6,887,350